Tennvall J - Search Results

1

Tumour therapy with radionuclides: assessment of progress and problems.

Carlsson J, Forssell Aronsson E, Hietala SO, Stigbrand T, Tennvall J. Carlsson J, et al. Among authors: tennvall j. Radiother Oncol. 2003 Feb;66(2):107-17. doi: 10.1016/s0167-8140(02)00374-2. Radiother Oncol. 2003. PMID: 12648782 Review.

2

Radiotherapy for unresectable endocrine pancreatic carcinomas.

Tennvall J, Ljungberg O, Ahrén B, Gustavsson A, Nillson LO. Tennvall J, et al. Eur J Surg Oncol. 1992 Feb;18(1):73-6. Eur J Surg Oncol. 1992. PMID: 1310647 Review.

3

Rat testis as a radiobiological in vivo model for radionuclides.

Grafström G, Jönsson BA, El Hassan AM, Tennvall J, Strand SE. Grafström G, et al. Among authors: tennvall j. Radiat Prot Dosimetry. 2006;118(1):32-42. doi: 10.1093/rpd/nci328. Epub 2005 Jul 26. Radiat Prot Dosimetry. 2006. PMID: 16046556

4

Change in tumor-absorbed dose due to decrease in mass during fractionated radioimmunotherapy in lymphoma patients.

Hindorf C, Lindén O, Stenberg L, Tennvall J, Strand SE. Hindorf C, et al. Among authors: tennvall j. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):4003S-6S. Clin Cancer Res. 2003. PMID: 14506200

5

Small cell carcinoma of the oesophagus: a clinical and immunohistopathological review.

Tennvall J, Johansson L, Albertsson M. Tennvall J, et al. Eur J Surg Oncol. 1990 Apr;16(2):109-15. Eur J Surg Oncol. 1990. PMID: 1691109

6

Palliation of multiple bone metastases from prostatic carcinoma with strontium-89.

Tennvall J, Darte L, Lundgren R, el Hassan AM. Tennvall J, et al. Acta Oncol. 1988;27(4):365-9. doi: 10.3109/02841868809093556. Acta Oncol. 1988. PMID: 2462438

7

Prognostic value of histopathological response to radiotherapy and microvessel density in oral squamous cell carcinomas.

Brun E, Zätterström U, Kjellén E, Wahlberg P, Willén R, Brun A, Perfekt R, Tennvall J. Brun E, et al. Among authors: tennvall j. Acta Oncol. 2001;40(4):491-6. doi: 10.1080/028418601750288226. Acta Oncol. 2001. PMID: 11504309

8

Radio-immunotherapy dosimetry with special emphasis on SPECT quantification and extracorporeal immuno-adsorption.

Strand SE, Ljungberg M, Tennvall J, Norrgren K, Garkavij M. Strand SE, et al. Among authors: tennvall j. Med Biol Eng Comput. 1994 Sep;32(5):551-61. doi: 10.1007/BF02515314. Med Biol Eng Comput. 1994. PMID: 7845072 Review.

9

Radioimmunotherapy dosimetry--a review.

Strand SE, Jönsson BA, Ljungberg M, Tennvall J. Strand SE, et al. Among authors: tennvall j. Acta Oncol. 1993;32(7-8):807-17. doi: 10.3109/02841869309096140. Acta Oncol. 1993. PMID: 8305230 Review.

10

177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy.

Garkavij M, Nickel M, Sjögreen-Gleisner K, Ljungberg M, Ohlsson T, Wingårdh K, Strand SE, Tennvall J. Garkavij M, et al. Among authors: tennvall j. Cancer. 2010 Feb 15;116(4 Suppl):1084-92. doi: 10.1002/cncr.24796. Cancer. 2010. PMID: 20127957 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page